Zika

CDC updates Zika testing and management guidelinesPediatricians need to stay committed to following those infants with possible exposure to Zika to understand the effects of Zika infection and ensure appropriate care and services.
Study: Clinical trials indicate positive results for Zika vaccineThree Phase 1 human clinical trials evaluating the efficacy of an Army-developed Zika purified inactivated virus (ZPIV) vaccine have shown it to be safe and well tolerated, according to a recent study. Plus: Another study has found an association between postmenopausal vasomotor symptoms (VMS), including hot flashes and night sweats, and elevated risk of diabetes.
Have we dodged another Zika bullet?Now with mosquito season past in most parts of North America, it seems we can be confident the predicted spread will not come to pass—at least in this year.
CDC issues interim guidance on congenital Zika infectionNew interim guidance from The Centers for Disease Control and Prevention (CDC) emphasizes the need for standard screening and monitoring of infants with possible congenital Zika virus infection plus hearing screening and specific testing and evaluation in three clinical scenarios. Plus: Are at-risk women commonly tested for rectal gonorrhea, chlamydia? Also: According to a study, ovarian cancer may originate in fallopian tubes.
First Zika test for blood donations wins nod from FDA
Zika virus updatesThe CDC sets up a registry to document the disease in pregnancy and infants. Plus: A look at Zika, HIV infection. Also, Zika care standards updated.
5 things you need to know about Zika
5 things you need to know about ZikaSummer is mosquito season, and in recent years that has meant concern about Zika.
CDC issues advisory on Zika testingThe latest on testing guidelines for Zika from the CDC. Plus: Are corticosteroids effective when administered only hours before delivery? Also, a look at the prevalence of hepatitis C among pregnancy women in the United States.
Managing treatment options for atopic keratoconjunctivitisEye or eyelid involvement in atopic dermatitis is relatively uncommon. However, the frequency and severity of corneal complications may accompany atopic keratoconjunctivitis and lead to vision loss. In all but the mildest cases of AKC, treatment typically consists of corticosteroids; calcineurin inhibitors may be added in more severe cases.
Risk review supports safety of corneal crosslinkingSevere complications are rare (< 1%) after corneal crosslinking for progressive keratoconus. Some are preventable, some are manageable, but some may lead to a need for corneal transplantation